Watching Twist Bioscience Corporation? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planTwist Bioscience Corporation
www.twistbioscience.comAI Executive Summary
AI-powered analysis of 8-K filing content
Twist Bioscience Corporation completed a public offering of 3,125,000 shares at $96.00 per share, raising $300 million to fund expansion and ongoing projects. The underwriters exercised their option to purchase an additional 468,750 shares, demonstrating strong investor demand.
Key Takeaways
Twist Bioscience raised $300 million through a public offering of common stock at $96.00 per share
The underwriting syndicate (Goldman Sachs, William Blair, Leerink Partners, Guggenheim Securities) exercised their 30-day option to purchase 468,750 additional shares on August 5, 2026
2 more takeaways
Related Filings (1)
1 more filing from Twist Bioscience Corporation in the last 90 days
Filing Overview
What This Means
Twist Bioscience Corporation filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.